- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01943357
Improving Self Management Skills of Older Adults With Diabetes
April 24, 2017 updated by: Kate Lorig, Stanford University
Improving the Self Management Skills of Older Adults With Diabetes
The study will help determine if the Better Choices Better Health Diabetes program (community-based or online, also known as the Diabetes Self-Management Program) improves the hbA1C of people with Type-II diabetes.
The investigators will also examine 1) symptoms (fatigue, sleep, low blood sugar symptoms, depression, shortness of breath), 2) healthy behaviors (blood sugar monitoring; taking medications as prescribed; getting eye, foot, kidney and cholesterol exams; and activity), 3) the use of health care services.
This project is a translational study to demonstrate the effectiveness of the intervention in the context of a major insurer.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Self-report questionnaires and hbA1c capillary blood collection kits will be administered at baseline (prior to the intervention), six-months and twelve-months.
Differences between baseline and followup scores will be used to determine if participants have benefited from the intervention, using intent-to-treat methodology.
Subgroups and delivery method (small-group or on-line) will be compared using repeated measures and analyses of covariance.
Study Type
Interventional
Enrollment (Actual)
1000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94306
- Stanford University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- type 2 diabetes
- WellPoint insurance or medicare supplement plan participant
- 18 years or older
Exclusion Criteria:
- Treatment for cancer in past year
- Pregnant
- Under 18
- Previously taken a Stanford self-management program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Diabetes Self-Management Program
Behavioral: Diabetes Self Management Program.
Consists of either a six-week small-group face-to-face program with two peer leaders or an six-week peer-facilitated Internet-based program.
|
The interventions include modeling and action-planning to enhance self-efficacy.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Metabolic control HbA1C
Time Frame: Baseline to 12 months
|
Baseline to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Symptom:fatigue
Time Frame: Baseline to 12 months
|
Single item visual numeric scale.
Examined at baseline, 6 months and 12 months.
Paired t-tests used to assess if change significant.
|
Baseline to 12 months
|
|
symptom: sleep
Time Frame: Baseline to 12 months
|
Single item visual numeric scale.
Examined at baseline, 6 months and 12 months.
Paired t-tests used to assess if change significant.
|
Baseline to 12 months
|
|
symptom: PHQ-8 depression
Time Frame: Baseline to 12 months
|
8-item scale.
Examined at baseline, 6 months and 12 months.
Paired t-tests used to assess if any changes are significant.
|
Baseline to 12 months
|
|
symptoms: hypoglycemic index
Time Frame: Baseline to 12 months
|
7-item scale.
Examined at baseline, 6 months and 12 months.
Paired t-tests used to assess if any changes are significant.
|
Baseline to 12 months
|
|
health behavior: blood glucose monitoring
Time Frame: Baseline to 12 months
|
Self report of how often monitor glucose at baseline, 6 months and 12 months.
Paired t-tests used to assess if any changes are significant.
|
Baseline to 12 months
|
|
health behavior: medication adherence
Time Frame: baseline to 12 months
|
3-item scale collected at baseline, 6 months and 12 months.
Paired t-tests used to assess if any changes are significant.
|
baseline to 12 months
|
|
Health behavior: communication with physician
Time Frame: baseline to 12 months
|
3-item scale collected at baseline, 6 months and 12 months.
Paired t-tests used to assess if any changes are significant.
|
baseline to 12 months
|
|
health behavior: exercise
Time Frame: baseline to 12 months
|
Minutes of exercise during last week self-reported at baseline, 6-months and 12-months.
Paired t-tests used to assess if any changes are significant.
|
baseline to 12 months
|
|
health behavior/utilization: frequency of exams
Time Frame: baseline to 12 months
|
Self report of how often examine feet and have eye, cholesterol and kidney levels tested.
Collected at baseline, 6 months and 12 months.
Paired t-tests used to assess if any changes are significant.
|
baseline to 12 months
|
|
Health care utilization
Time Frame: baseline to 12 months
|
Physician, ED, hospital visits in last six-months.
Self reported at baseline, 6 months and 12 months.
Paired t-tests used to assess if any changes are significant.
|
baseline to 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kate Lorig, DPH, Stanford School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2013
Primary Completion (ACTUAL)
March 1, 2016
Study Completion (ACTUAL)
February 1, 2017
Study Registration Dates
First Submitted
September 9, 2013
First Submitted That Met QC Criteria
September 11, 2013
First Posted (ESTIMATE)
September 16, 2013
Study Record Updates
Last Update Posted (ACTUAL)
April 25, 2017
Last Update Submitted That Met QC Criteria
April 24, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 26679
- 109554 (OTHER_GRANT: NCOA)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceCompletedType 2 Diabetes Mellitus | Pre DiabetesAustralia
Clinical Trials on Diabetes Self Management Program
-
OsakidetzaFondo de Investigacion Sanitaria; Kronikgune-- Association Centre of International... and other collaboratorsCompleted
-
Stanford UniversityCompleted
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Gadjah Mada UniversityCompletedDiabetes Type 2Indonesia
-
Mutah UniversityCompleted
-
Stanford UniversityCompleted
-
Ragae DughmoshHamad Medical Corporation; Qatar University; Qatar National Research Fund; Primary...Not yet recruitingType 2 Diabetes Mellitus (T2DM) | Self-management | Diabetes Self-management
-
Kutahya Health Sciences UniversityCompletedDiabetes Mellitus, Type 2 | Patient Empowerment | EmpowermentTurkey
-
LMC Diabetes & Endocrinology Ltd.Completed
-
Evidation HealthHumana Co.Ltd.CompletedDiabetes Mellitus, Type 2United States